A group of researchers led by the Universities of Leicester and Nottingham has discovered genetic differences that put some people at higher risk than others of developing chronic lung disease.
Asthma pill targets airway muscles to decrease attacks
Results from a phase II clinical trial, experimental work on cells and computational modelling have together shown why the first pill for asthma in 20 years can help reduce asthma attacks.
Researchers from Leicester (UK) and Vancouver (Canada) have shown that the investigational drug, Fevipiprant (an oral, selective prostaglandin D2 receptor antagonist), reduces the amount of smooth muscle in the airway lining. The findings are published in Science Translational Medicine today (13 February).
Rapid blood pressure lowering safe for clot-buster-treated stroke patients
A major international study has found that rapidly lowering blood pressure safely reduces the risk of bleeding in the brain in stroke patients being treated with clot-busting drugs. The research, which was led in the UK by the University of Leicester and funded by the Stroke Association, will be published today (7 February) in The Lancet.
Innovative healthcare project to link patient data receives government funding
A project led by the University of Leicester is one of 10 projects announced to receive a share of £3 million Government funding to prove the potential of health data to transform lives.
Read More
New targeted oral treatments for severe asthma to be studied
A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.
Read MoreMRC IMPACT PhD opportunities with NIHR Leicester BRC
Applications are now open for a range of exciting projects to study Complex Disease for a September 2019 start, with many opportunities that involve working with the NIHR Leicester BRC.
Read More